Lateral Flow Assays Market worth USD 12.5 Bn by 2026 at a CAGR of 2%

According to a recent lateral flow assays market report by Future Market Insights (FMI), the lateral flow assays market was valued at US$ 11 Bn in 2021, is projected to reach US$ 12.5 Bn by 2026, and is anticipated to grow at a CAGR of around 2% over the projected period of 2022-2032. The high rate of infectious diseases around the …

Cleanroom Technologies Market will reach a value of USD 13.29 Billion by 2032 at a CAGR of 6%

The cleanroom technologies market study conducted by Future Market Insights is projected to expand at a CAGR of 6% to US$ 13.29 Bn by 2032, up from US$ 7 Bn in 2021. The rising demands for sterilized pharmaceutical formulations and the growing demand for medical device cleanrooms are driving this cleanroom technologies market growth. In the subsequent years, technological advancements in cleanroom technology and rising demand for …

Drug Discovery Services Market Size to be worth USD 50.9 Bn by 2032

The global demand for drug discovery services market is expected to rise at a 14.5% CAGR to acquire a valuation of US$ 50.9 Bn by the end of forecast period 2022-232. The global drug discovery services market size was valued at US$ 15.5 Bn in 2021 and is projected to reach a valuation of US$ 32 Bn by 2026 …

High-end Cellomics Market Worth USD 536.9 Mn by 2031 | Future Market Insights

According to a recent Future Market Insights (FMI) industry analysis, the demand in the high-end cellomics market is expected to top US$ 288.8 Mn in 2021, growing at a CAGR of 6.4% during the forecast period 2021-2031. High-end cellomics is a process that is utilized in drug discovery and biological research to identify substances such as small …

Cold Disposable Biopsy Forceps Market Is Expected to reach USD 1,215.0 Bn by 2031

According to a recent study by Future Market Insights (FMI), the cold disposable biopsy forceps market is expected to witness high growth during the forecast period. The market value is slated to increase from US$ 505.1 Mn in 2020 to over US$ 1.2 Bn by 2031 at 8.4% CAGR over the forecast period (2021-2031). The …

Needle-Free Injectors Market to Hit USD 42.79 Billion by 2032 | Future Market Insights

Global demand for Needle-Free Injectors Market is expected to rise at a yearly growth rate of 12% Y-o-Y to US$ 42.79 Billionin 2032 Needle-free injection is an innovative drug delivery technology that drives drugs to the skin using force which virtually nullifies the use of hypodermic needle. With growing preference for non-invasive drug delivery system and vaccines, adoption …

Radiopharmaceuticals Market to cross US$ 6.2 Bn by 2022, Says Future Market Insights

The global radiopharmaceuticals market stands at US$ 6.2 Bn as of now and is expected to reach US$ 9.5 Bn by the year 2032 at a CAGR of 4.3% between 2022 and 2032. Radiopharmaceuticals imply medications containing radioisotopes that could be used as both – therapeutic agents and diagnosis medications. Radiopharmaceuticals manage critical as well …

Regenerative Artificial Skin Market Expected to Witness a CAGR of 9.9% through year 2022-2032

In 2022, the Regenerative Artificial Skin Market is projected to be worth US$2,185.5 million. The entire market demand for regenerating artificial skin is anticipated to reach US$5,615.5 million by 2032, growing at a CAGR of 9.9% between 2022 and 2032. Regenerative Artificial Skin Market: Overview Global regenerative artificial skin market is undergoing changes due to the burn …

Peri-implantitis Treatment Market worth US$ 4.5 Bn by 2032 at a CAGR of 8.7% | Future Market Insights

The peri-implantitis treatment market is expected to reach a value of US$ 2.3 billion in 2022 and is projected to increase at a CAGR of 8.7% to reach US$ 4.5 billion by 2032. Peri implant disease is associated with two main entities – peri-implantitis and peri-implant mucositis. Peri-implant mucositis is an inflammatory reversible reaction in the …

Critical Care Drugs Market Future Scenarios, Growth and Analytical Insights – 2032 | Future Market Insights

Between 2022 and 2032, the global Critical Care Drugs Market is anticipated to expand steadily at a CAGR of roughly 5% to 6%, bringing in sizable profits. Critical Care Drugs market players – Pfizer Inc., Abbott, Cadila Pharmaceutica, Triveni chemicals, Haffkine Bio-Pharmaceutical Corporation Ltd., Neon Laboratories Limited, among others represent the global Critical Care Drugs market. The …